Application YC di Rhizome AI

Winter 2026Active

Rhizome AI ha partecipato a Y Combinator nel batch Winter 2026 come azienda B2B. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2026
Settore: B2B
Dimensione team: 1
Stato: Active
Lanciata: 2026

Founder

Chetan MishraFounder

Cosa fa Rhizome AI

It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.

Application YC di Rhizome AI, ricostruita

Domanda per Y Combinator

Rhizome AI, batch Winter 2026. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rhizome AI

Describe what your company does in 50 characters or less.

Agent Platform for Life Sciences

What is your company going to make? Please describe your product and what it does or will do.

We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.

Where do you live now, and where would the company be based after YC?

I live in New York City and the company is based there and remotely distributed.

Explain your decision regarding location.

New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Rhizome AI?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Rhizome AI (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Rhizome AI si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Rhizome AI?

Rhizome AI apparteneva al batch Winter 2026 di Y Combinator.

Chi ha fondato Rhizome AI?

Rhizome AI è stato fondato da Chetan Mishra.

Cosa fa Rhizome AI?

Agent Platform for Life Sciences

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Rhizome AI, e di ogni altro batch YC, è in YC Insights.